A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
Clinical trial NCT05269667 · TERMINATED
Trial details
- NCT number
- NCT05269667
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-02
- Primary completion
- 2023-10-26
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.